HUTCHMED (China) (HCM) Liabilities and Shareholders Equity (2015 - 2026)

HUTCHMED (China) (HCM) has reported Liabilities and Shareholders Equity for 12 consecutive years, with $1.7 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity fell 2.22% year-over-year to $1.7 billion; the TTM figure through Jun 2026 stood at $163904.8 billion (changed 0.0% YoY), while the FY2025 annual figure was $225.4 million, down 100.0% from the prior year.
• Liabilities and Shareholders Equity grew to $1.7 billion in Q2 2026 per HCM's latest filing, from $225.4 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $163901.0 billion in Q4 2024 and bottomed at $163786.0 in Q4 2023.
• Historically, Liabilities and Shareholders Equity has averaged $18212.1 billion across 5 years, with a median of $1.3 billion in 2024.
• Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity surged 100070222699.39% — and 2025, when it plunged 100.0%.
• HUTCHMED (China)'s Liabilities and Shareholders Equity stood at $131.6 million in 2022, then sank by 99.88% to $163786.0 in 2023, then soared by 100070222699.39% to $163901.0 billion in 2024, then slumped by 100.0% to $225.4 million in 2025, then surged by 670.35% to $1.7 billion in 2026.
• Business Quant data shows HCM's Liabilities and Shareholders Equity at $1.7 billion in Q2 2026, $225.4 million in Q4 2025, and $1.8 billion in Q2 2025.